Renalytix plc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Renalytix plc (RENXF) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $8.24 million as of 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Notes
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2024-11-19
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $8.24M.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $8.49M.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $9.34M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $8.37M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2024-09-30 | $8.24M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $8.49M 10-Q · filed 2024-11-19 |
| 2024-03-31 | $9.34M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.37M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $10.42M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $11.95M 10-K · filed 2024-09-30 |
| 2023-03-31 | $11.42M 6-K · filed 2023-06-09 |
| 2022-12-31 | $11.98M 6-K · filed 2023-03-30 |
| 2022-09-30 | $10.88M 6-K · filed 2022-11-30 |
| 2022-06-30 | $12.34M 10-K · filed 2023-09-28 |
| 2021-06-30 | $0.00 20-F · filed 2022-10-31 |